K-877 compound: Clinical Trials

3 trials of K-877 compound, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Terminated 1

Follow K-877 compound: new trials by email Literature Review of K-877 compound trials Research Report on K-877 compound

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
K-877, Placebo - Type2 Diabetes, Dyslipidemia
Phase 3TerminatedKowa Research Institute, Inc.105442017-03-232025-09-25
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function
K-877, Fenofibrate, Placebo (for K-877) - Severe Hypertriglyceridemia
Phase 3CompletedKowa Research Institute, Inc.5512016-11-282022-11-30
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment
K-877, Fenofibrate, Placebo (for K-877) - Severe Hypertriglyceridemia
Phase 3CompletedKowa Research Institute, Inc.4712016-11-262022-10-28

Conditions studied

Hypertriglyceridemia (2)  ·  Dyslipidemias (1)

Sponsors

Kowa Research Institute, Inc. (3)

Countries

Bulgaria (3)  ·  Czechia (3)  ·  Hungary (3)  ·  Poland (3)  ·  Russia (3)  ·  Ukraine (3)  ·  United States (3)  ·  Belarus (2)  ·  Georgia (2)  ·  Argentina (1)  ·  Brazil (1)  ·  Canada (1)  ·  Colombia (1)  ·  Denmark (1)  ·  France (1)

Top investigators

Aruna Pradhan, MD (1)  ·  Paul Ridker, MD (1)

Results publications

PMID 30342298, PMID 36342113